Current Practice and Future Perspectives of Neurological Conditions Caused by Neurodegeneration
Deadline for manuscript submissions: 25 March 2024 | Viewed by 1561
Interests: neurodegenerative diseases; amyotrophic lateral sclerosis; multiple sclerosis; Parkinson's disease; Alzheimer's disease; Huntington's disease; multiple system atrophy; prion diseases
Special Issues, Collections and Topics in MDPI journals
In recent decades researchers have been trying to enhance the development of reliable biomarkers for neurodegenerative diseases, while medical practice has been moving toward precision medicine. However, there is still an urgent need to identify disease-specific biomarkers to improve the early diagnostic workup, favor clinical classification and prognostic models, and facilitate the development of effective disease-modifying therapies. Most neurodegenerative disorders, including Alzheimer’s disease, Parkinson’s disease, multiple sclerosis and amyotrophic lateral sclerosis, are late onset, meaning there is some factor that changes as a person ages for each disease. One constant factor is that in each disease, neurons gradually lose function as the disease progresses with age. About 20–40% of healthy people between 60 and 78 years old experience discernable decrements in cognitive performance in several domains, including working, spatial, episodic memory, and processing speed.
This Special Issue aims to highlight the current knowledge regarding neurodegeneration pathogenic mechanisms and underline possible current practices and future perspectives in neurodegenerative diseases.
In this Special Issue, original articles and reviews are welcome. We look forward to receiving your contributions.
Dr. Lilla Bonanno
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- neurodegenerative diseases
- amyotrophic lateral sclerosis
- multiple sclerosis
- Parkinson's disease
- Alzheimer's disease
- Huntington's disease
- multiple system atrophy
- prion diseases